BioWisdom and AstraZeneca extend agreement

23 July 2006

Cambridge, UK-based BioWisdom, a market leader in delivering biological intelligence to the pharmaceutical industry, had extended its existing relationship with Anglo-Swedish drug major AstraZeneca.

The two companies have been working together to build specific Intelligence Networks to enhance AstraZeneca's drug discovery process. The London-headquartered firm will further evaluate BioWisdom's Sofia platform for the development of these networks elsewhere in the business. Further details were not disclosed.

According to BioWisdom, its Intelligence Networks allow unbiased, systematic analysis of problems and are used to support decision-making in all areas of the health care industry. The company helps clients to navigate the complex scientific and commercial issues involved in developing successful products. In April 2006, the UK firm acquired Lion Bioscience, the bioinformatics unit of LION biosciences AG and the SRS suite of data integration products.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight